Clinical trial
Type 1 Diabetes Aerobic and Resistance Exercise (T1-DARE)
NCT00148538 · Ottawa Hospital Research Institute, Other · Completed
Key facts
| NCT number | NCT00148538 |
|---|---|
| Title | Type 1 Diabetes Aerobic and Resistance Exercise (T1-DARE) |
| Official title | Type 1 Diabetes Aerobic and Resistance Exercise (T1-DARE) |
| Lead sponsor | Ottawa Hospital Research Institute, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 1 |
| Intervention type | Behavioral |
| Interventions | Resistance and/or Aerobic Exercise |
| Enrollment | 66 |
| Start date | Jul 1, 2005 |
| Primary completion | Dec 1, 2010 |
| Completion | Apr 1, 2012 |
| First posted | Sep 8, 2005 |
| Last update posted | Jul 23, 2019 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: